Surrozen (SRZN) Gains from Investment Securities (2020 - 2026)

Surrozen (SRZN) recorded quarterly Gains from Investment Securities of $41.1 million in Q1 2026, up 14.92% quarter-over-quarter from $35.8 million in Q4 2025, and up 10387.5% on a YoY basis from N/an in Q1 2025.

Surrozen (SRZN) Gains from Investment Securities (2020 - 2026) Analysis & Trends

Surrozen's Gains from Investment Securities history runs 7 years deep, the most recent figure standing at $41.1 million for Q1 2026.

  • In Q1 2026, Gains from Investment Securities rose 10387.5% year-over-year to $41.1 million; the TTM figure through Mar 2026 stood at $96.6 million (up 24550.26% YoY), while the FY2025 annual figure was $1.3 million, up 136.75% from the prior year.
  • Gains from Investment Securities was $41.1 million for Q1 2026 at Surrozen, up from $35.8 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $41.1 million in Q1 2026 to a low of -$6.5 million in Q1 2022.
  • Historically, Gains from Investment Securities has averaged $6.0 million across 5 years, with a median of $392000.0 in 2025.
  • Biggest YoY gain for Gains from Investment Securities was 838861.04% in 2023; the steepest drop was 101.57% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at $8.2 million in 2022, then slumped by 101.57% to -$128000.0 in 2023, then surged by 15475.78% to $19.7 million in 2024, then surged by 81.77% to $35.8 million in 2025, then increased by 14.92% to $41.1 million in 2026.
  • The last three Gains from Investment Securities figures came in at $41.1 million (Q1 2026), $35.8 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Surrozen 235,841.47 -106.67 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 41.11 Mn
Mar 31, 2026 41.11 Mn
Dec 31, 2025 35.77 Mn
Dec 31, 2025 35.77 Mn
Sep 30, 2025 1.24 Mn
Sep 30, 2025 1.24 Mn
Jun 30, 2025 1.22 Mn
Jun 30, 2025 1.22 Mn
Mar 31, 2025 392,000.00
Mar 31, 2025 392,000.00
Dec 31, 2024 19.68 Mn
Dec 31, 2024 19.68 Mn
Sep 30, 2024 9,000.00
Sep 30, 2024 9,000.00
Jun 30, 2024 9,000.00
Jun 30, 2024 9,000.00
Mar 31, 2024 63,000.00
Mar 31, 2024 63,000.00
Dec 31, 2023 -128,000.00
Dec 31, 2023 -128,000.00